1-7 of 7
Keywords: Depression
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Molecular Neuropsychiatry (2019) 5 (Suppl. 1): 34–43.
Published Online: 08 January 2020
...Lindsay M. Melhuish Beaupre; Vanessa F. Gonçalves; Clement C. Zai; Arun K. Tiwari; Ricardo S. Harripaul; Deanna Herbert; Natalie Freeman; Daniel J. Müller; James L. Kennedy Sleep disturbance affects about 75% of depressed individuals and is associated with poorer patient outcomes. The genetics...
Journal Articles
Molecular Neuropsychiatry (2019) 5 (Suppl. 1): 44–59.
Published Online: 23 July 2019
...Caren J. Blacker; Vincent Millischer; Lauren M. Webb; Ada M.C. Ho; Martin Schalling; Mark A. Frye; Marin Veldic Glutamate is implicated in the neuropathology of both major depressive disorder and bipolar disorder. Excitatory amino acid transporter 2 (EAAT2) is the major glutamate transporter...
Journal Articles
Journal Articles
Molecular Neuropsychiatry (2016) 2 (3): 115–123.
Published Online: 29 June 2016
... hypomanic, 11 depressed) were started on lithium monotherapy. Closely matched healthy subjects (n = 15) were included as controls but did not receive treatment. Blood RNA samples were collected at baseline and after 2 and 8 weeks of treatment. RNA expression was measured using the Affymetrix GeneChip® Human...
Journal Articles
Journal Articles
Molecular Neuropsychiatry (2015) 1 (3): 145–155.
Published Online: 31 July 2015
...C. Anthony Altar; Joseph Carhart; Josiah D. Allen; Daniel Hall-Flavin; Joel Winner; Bryan Dechairo DNA of 258 patients with treatment-resistant depression was collected in three 8-10 week, two-arm, prospective clinical trials. Forty-four allelic variations were measured in genes for the cytochrome...
Journal Articles
Molecular Neuropsychiatry (2015) 1 (1): 1–12.
Published Online: 08 January 2015
..., despite its heavy burden and high prevalence, the molecular characterization of major depressive disorder (MDD) has lagged behind. Transcriptome studies report multiple brain disturbances but are limited by small sample sizes. Genome-wide association studies (GWAS) report weak results but suggest...